Akt and some types of cancer - Youness, Eman Refaat
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Cancer has the highest incidence and causes the most mortality worldwide. The phosphatidylinositol 3-kinase (PI3K)/Protein Kinase B (PKB, Akt) pathway is considered to be one of the most frequently altered pathways in human cancer with documented high relevance to tumour growth, metastatic spread, and resistance to anticancer treatment. Many human solid tumours harbour genetic alterations driving aberrant activation of the survival kinase Akt such as oncogenic activation of receptor tyrosine kinases, RAS or phosphatidylinositol-3-kinase (PI3K), loss of the tumour suppressor PTEN, or genomic…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cancer has the highest incidence and causes the most mortality worldwide. The phosphatidylinositol 3-kinase (PI3K)/Protein Kinase B (PKB, Akt) pathway is considered to be one of the most frequently altered pathways in human cancer with documented high relevance to tumour growth, metastatic spread, and resistance to anticancer treatment. Many human solid tumours harbour genetic alterations driving aberrant activation of the survival kinase Akt such as oncogenic activation of receptor tyrosine kinases, RAS or phosphatidylinositol-3-kinase (PI3K), loss of the tumour suppressor PTEN, or genomic amplification or gain-of-function mutations in one of the three known human Akt isoforms Akt1 (PKB ), Akt2 (PKBbeta) and Akt3 (PKBGamma).
Autorenporträt
Dr Eman Refaat Youness, MD, Medical Biochemistry, Faculty of Medicine, Cairo University; Prof. of Medical Biochemistry, National Research Centre, Egypt. Areas of interest: xperimental design, clinical researches, DNA, PCR. The author has international publications, and is a member of international societies, reviewer and editor of many journals.